FDA Inspection 1248576 — Anna Hibbs, M.D.
The FDA completed an inspection of Anna Hibbs, M.D. on August 9, 2024 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 9, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cleveland, OH (United States)
Additional Details
Clinical Investigator (CI)